SCHEMBL22274283

SCHEMBL22274283

CC1(C)c2ccccc2-c2c(-c3ccccc3-c3nc(Cl)nc(-c4ccccc4)n3)cccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.36
ALOX15 P16050 2/20 0.35
TSHR P16473 2/20 0.35
ADORA3 P0DMS8 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA2B P29275 1/20 0.35
ADORA1 P30542 1/20 0.35
LMNA P02545 4/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
HTT P42858 2/20 0.33
HPGD P15428 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
ALDH1A1 P00352 3/20 0.32
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
ALPL P05186 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29768811 0.95 L3MBTL1 (0.38) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL16383750 0.95 L3MBTL1 (0.38) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL30205798 0.92 L3MBTL1 (0.36) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL23770429 0.92 L3MBTL1 (0.36) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL23770426 0.91 PDK2 (0.33) L3MBTL1LMNAMEN1KMT2AHPGD
SCHEMBL23697394 0.91 L3MBTL1 (0.39) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL27069005 0.88 LMNA (0.36) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL24297110 0.87 PDK2 (0.37) TSHRKMT2AKDM4EPDK2PGR
SCHEMBL17252444 0.87 L3MBTL1 (0.43) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL19193856 0.87 PDK2 (0.34) L3MBTL1ALOX15TSHRADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024039056-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2024-02-22 WO disclosed
US-20220085298-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE LT MATERIALS CO., LTD. (KR) 2022-03-17 US disclosed
WO-2020153758-A1 COMPOSITION, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE 엘티소재주식회사 2020-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220085298-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE ALDH1A2, OXER1, AOX1 L3MBTL1 2955/4885ALOX15 327/4885TSHR 3260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.